These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 26915789)

  • 1. Diacylglycerol lipase β inhibition reverses nociceptive behaviour in mouse models of inflammatory and neuropathic pain.
    Wilkerson JL; Ghosh S; Bagdas D; Mason BL; Crowe MS; Hsu KL; Wise LE; Kinsey SG; Damaj MI; Cravatt BF; Lichtman AH
    Br J Pharmacol; 2016 May; 173(10):1678-92. PubMed ID: 26915789
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Investigation of Diacylglycerol Lipase Alpha Inhibition in the Mouse Lipopolysaccharide Inflammatory Pain Model.
    Wilkerson JL; Donvito G; Grim TW; Abdullah RA; Ogasawara D; Cravatt BF; Lichtman AH
    J Pharmacol Exp Ther; 2017 Dec; 363(3):394-401. PubMed ID: 28970359
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Liposomal Delivery of Diacylglycerol Lipase-Beta Inhibitors to Macrophages Dramatically Enhances Selectivity and Efficacy in Vivo.
    Shin M; Snyder HW; Donvito G; Schurman LD; Fox TE; Lichtman AH; Kester M; Hsu KL
    Mol Pharm; 2018 Mar; 15(3):721-728. PubMed ID: 28901776
    [TBL] [Abstract][Full Text] [Related]  

  • 4. WWL70 protects against chronic constriction injury-induced neuropathic pain in mice by cannabinoid receptor-independent mechanisms.
    Wen J; Jones M; Tanaka M; Selvaraj P; Symes AJ; Cox B; Zhang Y
    J Neuroinflammation; 2018 Jan; 15(1):9. PubMed ID: 29310667
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The involvement of the TRPA1 receptor in a mouse model of sympathetically maintained neuropathic pain.
    Pinheiro Fde V; Villarinho JG; Silva CR; Oliveira SM; Pinheiro Kde V; Petri D; Rossato MF; Guerra GP; Trevisan G; Antonello Rubin M; Geppetti P; Ferreira J; André E
    Eur J Pharmacol; 2015 Jan; 747():105-13. PubMed ID: 25498793
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined inhibition of FAAH and COX produces enhanced anti-allodynic effects in mouse neuropathic and inflammatory pain models.
    Grim TW; Ghosh S; Hsu KL; Cravatt BF; Kinsey SG; Lichtman AH
    Pharmacol Biochem Behav; 2014 Sep; 124():405-11. PubMed ID: 25058512
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The α7 nicotinic receptor dual allosteric agonist and positive allosteric modulator GAT107 reverses nociception in mouse models of inflammatory and neuropathic pain.
    Bagdas D; Wilkerson JL; Kulkarni A; Toma W; AlSharari S; Gul Z; Lichtman AH; Papke RL; Thakur GA; Damaj MI
    Br J Pharmacol; 2016 Aug; 173(16):2506-20. PubMed ID: 27243753
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Opioid and cannabinoid synergy in a mouse neuropathic pain model.
    Kazantzis NP; Casey SL; Seow PW; Mitchell VA; Vaughan CW
    Br J Pharmacol; 2016 Aug; 173(16):2521-31. PubMed ID: 27278681
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-allodynic and anti-oedematogenic properties of the extract and lignans from Phyllanthus amarus in models of persistent inflammatory and neuropathic pain.
    Kassuya CA; Silvestre AA; Rehder VL; Calixto JB
    Eur J Pharmacol; 2003 Oct; 478(2-3):145-53. PubMed ID: 14575799
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of alpha5 nicotinic acetylcholine receptors in mouse models of chronic inflammatory and neuropathic pain.
    Bagdas D; AlSharari SD; Freitas K; Tracy M; Damaj MI
    Biochem Pharmacol; 2015 Oct; 97(4):590-600. PubMed ID: 25931144
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of AAK1 Kinase as a Novel Therapeutic Approach to Treat Neuropathic Pain.
    Kostich W; Hamman BD; Li YW; Naidu S; Dandapani K; Feng J; Easton A; Bourin C; Baker K; Allen J; Savelieva K; Louis JV; Dokania M; Elavazhagan S; Vattikundala P; Sharma V; Das ML; Shankar G; Kumar A; Holenarsipur VK; Gulianello M; Molski T; Brown JM; Lewis M; Huang Y; Lu Y; Pieschl R; O'Malley K; Lippy J; Nouraldeen A; Lanthorn TH; Ye G; Wilson A; Balakrishnan A; Denton R; Grace JE; Lentz KA; Santone KS; Bi Y; Main A; Swaffield J; Carson K; Mandlekar S; Vikramadithyan RK; Nara SJ; Dzierba C; Bronson J; Macor JE; Zaczek R; Westphal R; Kiss L; Bristow L; Conway CM; Zambrowicz B; Albright CF
    J Pharmacol Exp Ther; 2016 Sep; 358(3):371-86. PubMed ID: 27411717
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-allodynic effects of obtusifolin and gluco-obtusifolin against inflammatory and neuropathic pain.
    He ZW; Wei W; Li SP; Ling Q; Liao KJ; Wang X
    Biol Pharm Bull; 2014; 37(10):1606-16. PubMed ID: 25070277
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antihyperalgesic, Antiallodynic, and Antinociceptive Effects of Cebranopadol, a Novel Potent Nociceptin/Orphanin FQ and Opioid Receptor Agonist, after Peripheral and Central Administration in Rodent Models of Neuropathic Pain.
    Tzschentke TM; Linz K; Frosch S; Christoph T
    Pain Pract; 2017 Nov; 17(8):1032-1041. PubMed ID: 28112482
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential effect of LPS and paclitaxel on microglial functional phenotypes and circulating cytokines: the possible role of CX3CR1 and IL-4/10 in blocking persistent inflammation.
    Ha JW; You MJ; Park HS; Kim JW; Kwon MS
    Arch Pharm Res; 2019 Apr; 42(4):359-368. PubMed ID: 30852731
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spinal inhibition of p38 MAP kinase reduces inflammatory and neuropathic pain in male but not female mice: Sex-dependent microglial signaling in the spinal cord.
    Taves S; Berta T; Liu DL; Gan S; Chen G; Kim YH; Van de Ven T; Laufer S; Ji RR
    Brain Behav Immun; 2016 Jul; 55():70-81. PubMed ID: 26472019
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The endocannabinoid hydrolysis inhibitor SA-57: Intrinsic antinociceptive effects, augmented morphine-induced antinociception, and attenuated heroin seeking behavior in mice.
    Wilkerson JL; Ghosh S; Mustafa M; Abdullah RA; Niphakis MJ; Cabrera R; Maldonado RL; Cravatt BF; Lichtman AH
    Neuropharmacology; 2017 Mar; 114():156-167. PubMed ID: 27890602
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intrathecal administration of NTS1 agonists reverses nociceptive behaviors in a rat model of neuropathic pain.
    Guillemette A; Dansereau MA; Beaudet N; Richelson E; Sarret P
    Eur J Pain; 2012 Apr; 16(4):473-84. PubMed ID: 22396077
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Histamine H
    Sanna MD; Lucarini L; Durante M; Ghelardini C; Masini E; Galeotti N
    Br J Pharmacol; 2017 Jan; 174(1):28-40. PubMed ID: 27714773
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interleukin-17 contributes to neuroinflammation and neuropathic pain following peripheral nerve injury in mice.
    Kim CF; Moalem-Taylor G
    J Pain; 2011 Mar; 12(3):370-83. PubMed ID: 20889388
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Topical gabapentin gel alleviates allodynia and hyperalgesia in the chronic sciatic nerve constriction injury neuropathic pain model.
    Shahid M; Subhan F; Ahmad N; Ali G; Akbar S; Fawad K; Sewell RD
    Eur J Pain; 2017 Apr; 21(4):668-680. PubMed ID: 27862616
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.